|
WO2021071823A1
|
|
Compositions and methods for pulmonary surfactant-biomimetic nanoparticles
|
|
WO2021067799A1
|
|
Methods and materials for modulating nrf2 pathway
|
|
US2021104294A1
|
|
Method for predicting hla-binding peptides using protein structural features
|
|
WO2021062413A1
|
|
System and method for deep learning for inverse problems without training data
|
|
WO2021067162A1
|
|
Droplet-based single extracellular vesicle sequencing
|
|
WO2021062268A1
|
|
Therapeutic neutralization antibodies for the treatment of peanut allergy
|
|
WO2021055437A1
|
|
Cd70 targeted chimeric antigen receptor (car) t cells and uses thereof
|
|
WO2021051064A1
|
|
System and method for determining treatment outcomes for neurological disorders based on functional connectivity parameters
|
|
WO2021042047A1
|
|
C-to-g transversion dna base editors
|
|
WO2021041873A1
|
|
Dynamic profiling of antitumor activity of car t cells using micropatterned tumor array devices
|
|
WO2021041429A1
|
|
System and method for high-resolution, high-speed capsule endomicroscopy
|
|
WO2021035038A1
|
|
Single-cell modeling of clinical data to determine red blood cell regulation
|
|
WO2021030627A1
|
|
Methods for predicting outcomes of checkpoint inhibition and treatment thereof
|
|
WO2021041006A2
|
|
Systems and methods for tourniquet operation and control
|
|
WO2021026395A1
|
|
Compounds, pharmaceutical compositions, and methods of their use in reversing cancer chemoresistance
|
|
US2020360576A1
|
|
Systems and methods that facilitate tattoo removal
|
|
US2021032702A1
|
|
Lineage inference from single-cell transcriptomes
|
|
WO2021025959A1
|
|
Targeting the gastrointestinal barrier to treat age-related disorders
|
|
WO2021016457A1
|
|
Methods of creating a substance with different freezing points by encapsulation
|
|
WO2021016054A1
|
|
Self-assembled vaccines and combination therapies for treating cancer
|
